Transaction · 0001415889-25-004845

Fordyce Marshall

Fordyce Marshall, PRES, reported a transaction classified as grant at Vera Therapeutics, Inc. involving 161500.000000 shares for an estimated $0.00. Reported holdings after the transaction were 161500.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES
VERAVera Therapeutics, Inc.
Filing timeFeb 20
Trade dateFeb 18, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

VERA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
VERA since 2025-02-20Filed 562 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001415889-25-004845
Stock Option (right to buy)
Transaction date
Feb 18, 2025
Filed Feb 20, 2025, 09:07 PM · 2d delay
Shares
161k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
161k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

PRESIDENT AND CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs, rounded to the nearest who…

  2. F2

    1/48 of the shares subject to the stock option will vest and become exercisable on March 18, 2025, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the…

Original filing · 0001415889-25-004845
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

VERA